Your browser doesn't support javascript.
loading
Quantitative Multiplexed Proteomics Could Assist Therapeutic Decision Making in Non-Small Cell Lung Cancer Patients with Ambiguous ALK Test Results.
An, Ho Jung; An, Eunkyung; Rabizadeh, Shahrooz; Liao, Wei-Li; Burrows, Jon; Hembrough, Todd; Kang, Jin Hyung; Park, Chan Kwon; Kim, Tae-Jung.
Afiliação
  • An HJ; Department of Medical Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • An E; NantOmics, Culver City, CA 90232, USA.
  • Rabizadeh S; NantOmics, Culver City, CA 90232, USA.
  • Liao WL; NantOmics, Culver City, CA 90232, USA.
  • Burrows J; OncoPlex Diagnostics, Rockville, MD 20850, USA.
  • Hembrough T; OncoPlex Diagnostics, Rockville, MD 20850, USA.
  • Kang JH; Department of Medical Oncology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Park CK; Division of Pulmonology, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Kim TJ; Department of Hospital Pathology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Cancers (Basel) ; 13(10)2021 May 12.
Article em En | MEDLINE | ID: mdl-34066104

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article